Zogenix (ZGNX +17.4%) soars as investors are pleased with the company's Tuesday evening update on Zohydro ER.The company and the FDA have wrapped up the final labeling for the drug pursuant to the regulator's announced changes to safety labeling standards for ER and LA opioid analgesics.The drug — which, notably, is the first acetaminophen-free ER hydrocodone — will be classified as a Schedule II drug in contrast to popular hydrocodone-acetaminophen combo products which are Schedule III.It appears the only thing holding up an FDA decision is the government shutdown, although PDUFA activities are supposed to be operational.
==============================================================
FDA approval will make this soar even further.
Take Care and God Bless....God Bless Us All.
Truth4Once
I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of solutions.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM